Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Qianjiang Yongan Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥58.18 Million ≈ $8.51 Million USD) by net assets (CN¥2.02 Billion ≈ $294.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)

Cash flow conversion efficiency of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. This chart illustrates how Qianjiang Yongan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002365 share price today for real-time trading data and today's change.

Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Qianjiang Yongan Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Qianjiang Yongan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qianjiang Yongan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Qianjiang Yongan Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shanghai Baosight Software Co Ltd B SHG:900926	0.054x
W&T Offshore Inc NYSE:WTI	-0.171x
Potbelly Co NASDAQ:PBPB	0.225x
SD Biosensor Inc KO:137310	0.001x
Zhongjin Irradiation Incorporated Company SHE:300962	0.043x
Grenevia S.A. WAR:GEA	0.070x
Shanghai Golden Bridge SHG:603918	0.043x
Savita Oil Technologies Limited NSE:SOTL	0.051x

Annual Cash Flow Conversion Efficiency for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. Review 002365 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.04 Billion ≈ $298.82 Million	CN¥105.71 Million ≈ $15.47 Million	0.052x	-56.59%
2023-12-31	CN¥2.05 Billion ≈ $299.73 Million	CN¥244.26 Million ≈ $35.74 Million	0.119x	-35.25%
2022-12-31	CN¥2.10 Billion ≈ $307.74 Million	CN¥387.28 Million ≈ $56.67 Million	0.184x	+253.98%
2021-12-31	CN¥1.96 Billion ≈ $286.37 Million	CN¥101.81 Million ≈ $14.90 Million	0.052x	-54.34%
2020-12-31	CN¥1.81 Billion ≈ $265.42 Million	CN¥206.66 Million ≈ $30.24 Million	0.114x	-21.20%
2019-12-31	CN¥1.66 Billion ≈ $242.43 Million	CN¥239.55 Million ≈ $35.05 Million	0.145x	-26.06%
2018-12-31	CN¥1.61 Billion ≈ $235.00 Million	CN¥314.02 Million ≈ $45.95 Million	0.196x	+33.26%
2017-12-31	CN¥1.34 Billion ≈ $196.77 Million	CN¥197.32 Million ≈ $28.87 Million	0.147x	+104.33%
2016-12-31	CN¥1.18 Billion ≈ $172.25 Million	CN¥84.53 Million ≈ $12.37 Million	0.072x	+13.87%
2015-12-31	CN¥1.12 Billion ≈ $163.82 Million	CN¥70.61 Million ≈ $10.33 Million	0.063x	+262.73%
2014-12-31	CN¥1.11 Billion ≈ $162.12 Million	CN¥19.26 Million ≈ $2.82 Million	0.017x	-70.50%
2013-12-31	CN¥1.08 Billion ≈ $158.02 Million	CN¥63.65 Million ≈ $9.31 Million	0.059x	-8.84%
2012-12-31	CN¥1.09 Billion ≈ $160.11 Million	CN¥70.75 Million ≈ $10.35 Million	0.065x	-25.14%
2011-12-31	CN¥1.06 Billion ≈ $154.57 Million	CN¥91.23 Million ≈ $13.35 Million	0.086x	+98.86%
2010-12-31	CN¥1.01 Billion ≈ $148.46 Million	CN¥44.06 Million ≈ $6.45 Million	0.043x	-61.35%
2009-12-31	CN¥324.17 Million ≈ $47.44 Million	CN¥36.43 Million ≈ $5.33 Million	0.112x	-81.62%
2008-12-31	CN¥259.12 Million ≈ $37.92 Million	CN¥158.47 Million ≈ $23.19 Million	0.612x	+91.78%
2007-12-31	CN¥191.53 Million ≈ $28.03 Million	CN¥61.08 Million ≈ $8.94 Million	0.319x	+7.60%
2006-12-31	CN¥104.99 Million ≈ $15.36 Million	CN¥31.11 Million ≈ $4.55 Million	0.296x	--

About Qianjiang Yongan Pharmaceutical Co Ltd

SHE:002365 China Drug Manufacturers - Specialty & Generic

Market Cap

$517.46 Million

CN¥3.54 Billion CNY

Market Cap Rank

#11672 Global

#3265 in China

Share Price

CN¥12.00

Change (1 day)

-3.38%

52-Week Range

CN¥10.08 - CN¥17.84

All Time High

CN¥30.60